Ayalandi -
Kiingereza -
HPRA (Health Products Regulatory Authority)
bricanyl sa 7.5 milligram tablets
astrazeneca uk limited - terbutaline sulfate - tablets - 7.5 milligram
Uingereza -
Kiingereza -
MHRA (Medicines & Healthcare Products Regulatory Agency)
bambec 20mg tablets
astrazeneca uk ltd - bambuterol hydrochloride - oral tablet - 20mg
Uingereza -
Kiingereza -
MHRA (Medicines & Healthcare Products Regulatory Agency)
bambec 20mg tablets
sigma pharmaceuticals plc - bambuterol hydrochloride - oral tablet - 20mg
Ayalandi -
Kiingereza -
HPRA (Health Products Regulatory Authority)
bricanyl compound
astra pharmaceuticals ltd - terbutaline sulfate guaifenesin - tablets
Nyuzilandi -
Kiingereza -
Medsafe (Medicines Safety Authority)
bricanyl durules
astrazeneca limited - terbutaline sulfate 7.5mg - modified release tablet - 7.5 mg - active: terbutaline sulfate 7.5mg excipient: colloidal silicon dioxide ethylcellulose polyvinyl chloride stearyl alcohol tartaric acid
Misri -
Kiingereza -
EDA (Egyptian Drug Authority)
bricanyl 2.5mg tab.
astra zeneca sweden - tablet - 2.5 mg
Filipino -
Kiingereza -
FDA (Food And Drug Administration)
bricanyl® 2.5mg tablet
astrazeneca pharmaceuticals (phils.), inc.; distributor: astrazeneca pharmaceuticals (phils.), inc. - terbutaline sulfate - tablet - 2.5mg
Kanada -
Kiingereza -
Health Canada
bricanyl tab 5 mg tablet
astrazeneca canada inc - terbutaline sulfate - tablet - 5mg - terbutaline sulfate 5mg - selective beta 2-adrenergic agonists
Kanada -
Kiingereza -
Health Canada
bricanyl tab 2.5 mg tablet
astrazeneca canada inc - terbutaline sulfate - tablet - 2.5mg - terbutaline sulfate 2.5mg - selective beta 2-adrenergic agonists
Nyuzilandi -
Kiingereza -
Medsafe (Medicines Safety Authority)
bricanyl turbuhaler
astrazeneca limited - terbutaline sulfate 0.25mg; terbutaline sulfate 200ug equivalent to 0.25 mg metered dose - powder for inhalation - 0.25 mg/dose - active: terbutaline sulfate 0.25mg terbutaline sulfate 200ug equivalent to 0.25 mg metered dose excipient: lactose monohydrate - relief of bronchospasm occurring in bronchial asthma, bronchitis and other bronchopulmonary conditions where bronchospasm is a complicating factor. acute prophylaxis in situations known to induce bronchospasm, e.g. exercise induced asthma.